Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024 17

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024 17

Washington University will open second proton center for cancer treatment as others shut down

by Blythe BernhardCredit: CC0 Public DomainProton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis.As several otherproton&

Updated on: March 09,2024 18

Washington University will open second proton center for cancer treatment as others shut down

by Blythe BernhardCredit: CC0 Public DomainProton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis.As several otherproton&

Updated on:March 09,2024 18

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on: January 13,2024 17

Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainBlack women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women

Updated on:January 13,2024 17

Artificial intelligence tool developed to predict risk of lung cancer

byMassachusetts General HospitalCredit: CC0 Public DomainLung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is

Updated on: January 02,2024 10

Artificial intelligence tool developed to predict risk of lung cancer

byMassachusetts General HospitalCredit: CC0 Public DomainLung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is

Updated on:January 02,2024 10

Novel biomarker found in ovarian cancer patients can predict response to therapy

by University of Chicago Medical CenterTumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. C

Updated on: April 23,2024 13

Novel biomarker found in ovarian cancer patients can predict response to therapy

by University of Chicago Medical CenterTumor-specific expression of CT45 stimulates the patient's immune system to fight the cancer and improves the efficacy of platinum-based chemotherapy. C

Updated on:April 23,2024 13

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on: January 22,2024 10

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on:January 22,2024 10

Researchers find timing, dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence

by Bendta Schroeder,Massachusetts Institute of TechnologyNormal cells (blue) entering senescence (green to yellow) or apoptosis (purple to red) after treatment with chemotherapy. Credit: Bendta

Updated on: February 18,2024 17

Researchers find timing, dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence

by Bendta Schroeder,Massachusetts Institute of TechnologyNormal cells (blue) entering senescence (green to yellow) or apoptosis (purple to red) after treatment with chemotherapy. Credit: Bendta

Updated on:February 18,2024 17

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024 19

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024 19

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on: March 30,2024 16

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on:March 30,2024 16

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on: March 01,2024 15

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on:March 01,2024 15

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on: April 18,2024 0

Latest results from clinical trial show patients with advanced HER2-positive breast cancer live longer on pyrotinib

by Associação Advanced Breast Cancer Global AllianceCredit: Unsplash/CC0 Public DomainPatients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer

Updated on:April 18,2024 0

Colorectal cancer is rising among younger adults: Some states want to boost awareness

by Tim Henderson, Stateline.orgCredit: Francisco Farias Jr/public domainResponding to new research on the rising incidence of colorectal cancer among younger adults, some states are trying to boost pu

Updated on: March 20,2024 19

Colorectal cancer is rising among younger adults: Some states want to boost awareness

by Tim Henderson, Stateline.orgCredit: Francisco Farias Jr/public domainResponding to new research on the rising incidence of colorectal cancer among younger adults, some states are trying to boost pu

Updated on:March 20,2024 19